James M McKiernan

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
    Melissa A Laudano
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    BJU Int 103:317-20. 2009
  2. doi request reprint Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure
    James M McKiernan
    Department of Urology, Herbert Irving Cancer Center, Columbia University Medical Center, New York, New York Electronic address
    J Urol 192:1633-8. 2014
  3. pmc Characteristic promoter hypermethylation signatures in male germ cell tumors
    Sanjay Koul
    Department of Pathology, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, New York, NY, 10032, USA
    Mol Cancer 1:8. 2002
  4. ncbi request reprint New treatments for superficial bladder cancer
    Jay B Shah
    Department of Urology, Columbia University Medical Center, Herbert Irving Pavilion, 11th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Oncol Rep 8:201-5. 2006
  5. doi request reprint The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy
    Daniel J Lee
    Department of Urology, Columbia University Medical Center, Columbia University Mailman School of Public Health, New York, NY 10032, USA
    BJU Int 107:1741-7. 2011
  6. doi request reprint Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder
    Olga Yeshchina
    Department of Urology, Columbia University College of Physicians and Surgeons, Mailman School of Public Health, New York, New York 10032, USA
    Urology 79:384-90. 2012
  7. doi request reprint Independent diagnostic and post-treatment prognostic models for prostate cancer demonstrate significant correlation with disease progression end points
    Joseph A Graversen
    Department of Urology, University of California, Irvine, Irvine, California, USA
    J Endourol 26:451-6. 2012
  8. doi request reprint A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer
    Matthew S Wosnitzer
    Department of Urology, Columbia University Medical Center, New York, New York, USA
    Cancer 118:358-64. 2012
  9. ncbi request reprint Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent
    Scott M Gilbert
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    Urology 68:287-91. 2006
  10. doi request reprint The effect of race and gender on the surgical management of the small renal mass
    Max Kates
    Department of Urology, Columbia University Medical Center, New York, NY, USA Electronic address
    Urol Oncol 31:1794-9. 2013

Detail Information

Publications103 found, 100 shown here

  1. doi request reprint How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
    Melissa A Laudano
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    BJU Int 103:317-20. 2009
    ....
  2. doi request reprint Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure
    James M McKiernan
    Department of Urology, Herbert Irving Cancer Center, Columbia University Medical Center, New York, New York Electronic address
    J Urol 192:1633-8. 2014
    ..Results of the phase I intravesical trial of this compound demonstrated minimal toxicity during dose escalation. We now report the results of a phase II trial to assess efficacy...
  3. pmc Characteristic promoter hypermethylation signatures in male germ cell tumors
    Sanjay Koul
    Department of Pathology, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, New York, NY, 10032, USA
    Mol Cancer 1:8. 2002
    ..GCTs exhibit pluripotentiality and are highly sensitive to cisplatin therapy. The molecular basis of germ cell (GC) transformation, differentiation, and exquisite treatment response is poorly understood...
  4. ncbi request reprint New treatments for superficial bladder cancer
    Jay B Shah
    Department of Urology, Columbia University Medical Center, Herbert Irving Pavilion, 11th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Oncol Rep 8:201-5. 2006
    ..The myriad novel therapeutic modalities under exploration suggest that these goals may be achievable within our lifetime...
  5. doi request reprint The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy
    Daniel J Lee
    Department of Urology, Columbia University Medical Center, Columbia University Mailman School of Public Health, New York, NY 10032, USA
    BJU Int 107:1741-7. 2011
    ..Therapy (case series)...
  6. doi request reprint Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder
    Olga Yeshchina
    Department of Urology, Columbia University College of Physicians and Surgeons, Mailman School of Public Health, New York, New York 10032, USA
    Urology 79:384-90. 2012
    ..GC has often been used interchangeably with MVAC in neoadjuvant or adjuvant settings for patients with locally advanced (cT2N0M0-cT4N2M0) bladder cancer without adequate evidence...
  7. doi request reprint Independent diagnostic and post-treatment prognostic models for prostate cancer demonstrate significant correlation with disease progression end points
    Joseph A Graversen
    Department of Urology, University of California, Irvine, Irvine, California, USA
    J Endourol 26:451-6. 2012
    ..The purpose of this study is to calculate the percent agreement and the concordance between the Px+ and Px end points...
  8. doi request reprint A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer
    Matthew S Wosnitzer
    Department of Urology, Columbia University Medical Center, New York, New York, USA
    Cancer 118:358-64. 2012
    ..We compared patient outcomes following neoadjuvant or adjuvant systemic chemotherapy for cT2-T4aN0-N2M0 bladder cancer...
  9. ncbi request reprint Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent
    Scott M Gilbert
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    Urology 68:287-91. 2006
    ..We examined the relative survival rates of patients with T1 and T3a tumors to determine the accuracy of the current TNM staging classification...
  10. doi request reprint The effect of race and gender on the surgical management of the small renal mass
    Max Kates
    Department of Urology, Columbia University Medical Center, New York, NY, USA Electronic address
    Urol Oncol 31:1794-9. 2013
    ..To date, no population studies have been designed to assess the impact of race and gender on the rate of nephron-sparing surgery (NSS) across the United States...
  11. doi request reprint Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins
    Edan Y Shapiro
    1 Department of Urology, Columbia University Medical Center, New York, New York
    J Endourol 28:208-13. 2014
    ..We sought to evaluate whether the method of surgery (RP vs RARP) affects the rate of biochemical recurrence (BCR) in patients with PSMs...
  12. doi request reprint Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy
    Melissa A Laudano
    Department of Urology, Columbia University Medical Center, New York, New York, USA
    Urology 75:134-7. 2010
    ..We sought to determine long-term clinical outcomes after treatment with intravesical docetaxel...
  13. ncbi request reprint Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era
    Carl K Gjertson
    Department of Urology, Columbia University Medical Center, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Urology 70:723-7. 2007
    ..We examined a series of patients with Stage D1 (T2-T4N1-N2M0) prostate cancer discovered after RP, most of whom started ADT at biochemical recurrence...
  14. doi request reprint The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy
    Lamont J Barlow
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    BJU Int 105:1646-9. 2010
    ....
  15. ncbi request reprint Re-evaluation of the Tumour-Node-Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a)
    Alana M Murphy
    Department of Urology, Columbia University Medical Center, 161 Fort Washington Avenue, 11th Floor, New York, NY 10032, USA
    BJU Int 95:27-30. 2005
    ..They analysed their database of 717 such tumours between 1988 and 2002, and found that absolute tumour size was the more significant of the two findings...
  16. doi request reprint The effect of fibrin clot inhibitors on the immunomodulatory efficacy of Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer
    Michael J Lipsky
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    Urology 81:1273-8. 2013
    ....
  17. ncbi request reprint A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival
    Manlio A Goetzl
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Urol Oncol 22:182-7. 2004
    ..Metastatic renal cell carcinoma (RCC) is an aggressive entity that frequently invades the venous system. We evaluated the morbidity and survival of patients with tumor thrombus who undergo cytoreductive nephrectomy...
  18. doi request reprint Pathological tumour diameter predicts risk of conventional subtype in small renal cortical tumours
    Melissa A Laudano
    Department of Urology, Columbia University Medical Center, New York 10032, USA
    BJU Int 102:1385-8. 2008
    ..To examine whether pathological tumour diameter assists in predicting conventional vs other histological subtypes in renal cortical tumours (RCTs) of <or=4 cm diameter...
  19. ncbi request reprint Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors
    Scott M Gilbert
    Squier Urological Clinic, Columbia University Medical Center, New York, New York 10032, USA
    Urology 67:942-5. 2006
    ..To present extended follow-up on a cohort of patients with renal cortical tumors treated with partial or radical nephrectomy and preoperatively assess for carbonic anhydrase 9 tumor marker expression in the peripheral blood...
  20. doi request reprint Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy
    G Joel DeCastro
    Department of Urology, New York Presbyterian Hospital, Columbia University, New York, New York 10032, USA
    Urology 72:1214-8. 2008
    ..To determine whether present subclassifications for pathologic T2 (pT2) prostate cancer are predictive for recurrence-free survival (RFS) after radical prostatectomy...
  21. doi request reprint Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy
    Matthew S Wosnitzer
    Department of Urology, Columbia University College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    J Urol 186:2094-100. 2011
    ....
  22. doi request reprint Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma
    Michael J Lipsky
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    Urology 81:1190-5. 2013
    ..To determine the pattern of postoperative radiographic surveillance in patients with pT1a renal cell carcinoma (RCC) at a tertiary care hospital...
  23. doi request reprint Socioeconomic and clinical factors influence the interval between positive prostate biopsy and radical prostatectomy
    Max Pitman
    Department of Urology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA
    Urology 80:1027-32. 2012
    ..To examine socioeconomic and clinical factors that may predict a longer interval between prostate biopsy and radical prostatectomy (RP)...
  24. doi request reprint Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance
    Piruz Motamedinia
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    Urology 80:1070-4. 2012
    ..To assess the role of confirmatory prostate biopsy in the accurate risk assessment of patients with low risk prostate cancer eligible for active surveillance...
  25. doi request reprint The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy
    Alana M Murphy
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    BJU Int 105:176-9. 2010
    ....
  26. ncbi request reprint High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy
    Phillip M Pierorazio
    Departments of Urology, Columbia University Medical Center, New York, NY, USA
    BJU Int 100:1066-70. 2007
    ....
  27. doi request reprint Body mass index trends and role of obesity in predicting outcome after radical prostatectomy
    Piruz Motamedinia
    Albert Einstein College of Medicine, Bronx, New York, USA
    Urology 72:1106-10. 2008
    ..We examined BMI trends in patients undergoing radical prostatectomy (RP) and evaluated the role of obesity in predicting biochemical failure (BCF) after RP...
  28. doi request reprint Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison
    Chad R Ritch
    Department of Urology, Columbia University Medical Center NY Presbyterian Hospital, New York, NY 10032, USA
    BJU Int 111:E186-90. 2013
    ....
  29. doi request reprint Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?
    Gina M Badalato
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    BJU Int 110:1471-7. 2012
    ..To determine whether a survival difference exists between patients with high grade (HG) cT1 urothelial cell carcinoma (UCC) receiving immediate radical cystectomy (IRC) as opposed to those choosing bladder-sparing therapy...
  30. doi request reprint Predictors of locally advanced and metastatic disease in patients with small renal masses
    Max Kates
    Department of Urology, Mount Sinai School of Medicine, New York, NY, USA
    BJU Int 109:1463-7. 2012
    ..In a large sampling of the US population, older patients and men were more likely to have small renal masses at an advanced stage...
  31. doi request reprint Does absolute neutrophil count predict high tumor grade in African-American men with prostate cancer?
    Neda Sadeghi
    Squier Urological Clinic, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA
    Prostate 72:386-91. 2012
    ....
  32. doi request reprint Accuracy of the Kattan nomogram across prostate cancer risk-groups
    Ruslan Korets
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    BJU Int 108:56-60. 2011
    ..To investigate the predictive ability of nomograms at the extremes of preoperative clinical parameters by examining the predictive ability across all prostate cancer risk groups...
  33. ncbi request reprint Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomy
    Robert E Mitchell
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 175:1663-7; discussion 1667. 2006
    ..We determined whether the impact of PSA in predicting biochemical failure after radical prostatectomy has changed since the beginning of the PSA era...
  34. ncbi request reprint Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer
    Robert E Mitchell
    J Bentley Squier Urologic Clinic, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Urology 70:706-10. 2007
    ....
  35. ncbi request reprint Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus
    Erica H Lambert
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Urology 69:1054-8. 2007
    ..Often, these patients also present with metastatic disease. This study examined the clinical outcome and morbidity of patients with RCC and vascular tumor thrombus treated with aggressive surgical therapy...
  36. ncbi request reprint The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy
    Erica H Lambert
    Urology, Columbia University Medical Center, New York, NY, USA
    BJU Int 100:33-6. 2007
    ..This study examines the patterns of use of IVT in high-grade T1 bladder cancer and the subsequent impact on survival for patients ultimately proceeding to radical cystectomy (RC)...
  37. ncbi request reprint Natural history and clinical outcome of sporadic renal cortical tumors diagnosed in the young adult
    Manlio A Goetzl
    Department of Urology, Columbia University College of Physicians and Surgeons and Columbia University Mailman School of Public Health, New York, New York 10032, USA
    Urology 63:41-5. 2004
    ....
  38. doi request reprint Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapy
    Lamont J Barlow
    Department of Urology, Columbia University Medical Center, New York Presbyterian Hospital, New York, New York 10032, USA
    J Urol 189:834-9. 2013
    ..Docetaxel is a safe agent for intravesical therapy. Adding monthly maintenance treatments can extend response durability. We report our cumulative experience with intravesical docetaxel in a larger cohort with extended followup...
  39. doi request reprint The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience
    Lamont J Barlow
    Department of Urology, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, Herbert Irving Pavilion 11th Floor, 161 Fort Washington Ave, New York, NY 10032, USA
    World J Urol 27:331-5. 2009
    ..This study analyzes the safety and efficacy of intravesical docetaxel in a larger patient population with extended follow-up...
  40. ncbi request reprint The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma
    Neda Sadeghi
    Department of Urology, Squier Urological Clinic, Columbia University Medical Center, New York, New York 10032, USA
    Can J Urol 19:6443-9. 2012
    ..Perioperative blood transfusion (PBT) has been shown to contribute to cancer progression and mortality. This study sought to determine the impact of PBT during radical cystectomy on cancer-specific survival (CSS) and overall survival (OS)...
  41. doi request reprint Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ
    Edan Y Shapiro
    Department of Urology, Columbia University Medical Center, New York, NY, USA
    J Endourol 26:1645-50. 2012
    ..We report our experience using a novel technique to directly instill BCG with interferon-α2B (BCG/IFN) into the upper-tract in patients with biopsy-proven UT-CIS...
  42. doi request reprint Routine transition zone biopsy during active surveillance for prostate cancer rarely provides unique evidence of disease progression
    Jamie L Richard
    Department of Urology, Columbia University Medical Center, College of Physicians and Surgeons, NewYork Presbyterian Hospital, New York, New York 10032, USA
    J Urol 188:2177-80. 2012
    ..We evaluated the usefulness of transition zone biopsy in patients with prostate cancer enrolled in active surveillance...
  43. doi request reprint Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion
    Mark S Godfrey
    Columbia University Medical Center, Department of Urology, New York, NY, USA
    BJU Int 110:798-803. 2012
    ..Such evidence may support the addition of LVI to future TNM staging algorithms for UTUC...
  44. pmc Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
    Sanjay Koul
    Department of Pathology, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, New York, NY 10032, USA
    Mol Cancer 3:16. 2004
    ..Male germ cell tumor (GCT) is a highly curable malignancy, which exhibits exquisite sensitivity to cisplatin treatment. The genetic pathway(s) that determine the chemotherapy sensitivity in GCT remain largely unknown...
  45. doi request reprint Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein
    Solomon L Woldu
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    Urology 76:639-42. 2010
    ..To assess our institution's experience with the management of pathologic stage T3bNxM0 renal cell carcinoma with tumor thrombus confined to the renal vein treated with nephron-sparing surgery (NSS)...
  46. doi request reprint Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomy
    Matthew D Truesdale
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    J Endourol 25:1427-33. 2011
    ..We studied the impact of statin use on BL during robot-assisted radical prostatectomy (RARP) and open radical prostatectomy (ORP)...
  47. doi request reprint Heparin prophylaxis and the risk of venous thromboembolism after robotic-assisted laparoscopic prostatectomy
    Trushar Patel
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    BJU Int 108:729-32. 2011
    ..The incidence of venous thromboembolism (VTE) after robotic-assisted laparoscopic prostatectomy (RALP) in patients receiving perioperative heparin prophylaxis was compared with those who did not receive such prophylaxis...
  48. doi request reprint A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies
    Joshua R Gonzalez
    Department of Urology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, 11th Floor, New York, NY, 10032, USA
    World J Urol 26:475-80. 2008
    ....
  49. ncbi request reprint Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed
    Phillip M Pierorazio
    Department of Urology, Columbia University Medical Center, New York, NY, USA
    BJU Int 100:755-9. 2007
    ....
  50. ncbi request reprint Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy
    Phillip M Pierorazio
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Urology 70:717-22. 2007
    ..To assess the likelihood of biochemical disease-free survival, urinary continence, and sexual potency after radical retropubic prostatectomy (RRP) as an aggregate outcome, the "trifecta" analysis...
  51. ncbi request reprint Does year of radical prostatectomy independently predict outcome in prostate cancer?
    Robert E Mitchell
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Urology 67:368-72. 2006
    ..Since the beginning of the PSA era, the presentation, treatment, and therapeutic outcomes of prostate cancer have evolved...
  52. doi request reprint A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancer
    James M McKiernan
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    J Urol 186:448-51. 2011
    ..Thus, we assessed the dose limiting toxicity and maximum deliverable dose of intravesical nanoparticle albumin-bound paclitaxel...
  53. ncbi request reprint Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression
    Laurent Salomon
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Urology 62:304-9. 2003
    ..To evaluate and study the factors for progression after radical prostatectomy with seminal vesicle invasion in a cohort of European and American patients...
  54. doi request reprint Who really benefits from nephron-sparing surgery?
    Solomon L Woldu
    Department of Urology, Columbia University Medical Center, New York, NY Electronic address
    Urology 84:860-7. 2014
    ....
  55. doi request reprint Secondary bladder cancer after upper tract urothelial carcinoma in the US population
    Max Kates
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    BJU Int 110:1325-9. 2012
    ....
  56. doi request reprint Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis
    Ruslan Korets
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    BJU Int 110:211-6. 2012
    ..Men with localized prostate cancer can be reassured that reasonable delays in treatment will not influence disease outcomes...
  57. doi request reprint Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach
    Gina M Badalato
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    BJU Int 109:1457-62. 2012
    ..This study employs a propensity scoring approach within a large US population-based cohort to determine that no survival differences exist among patients with T1b renal tumours undergoing partial versus radical nephrectomy...
  58. doi request reprint Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG
    Lamont J Barlow
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    Urol Oncol 28:108-11. 2010
    ..The most effective treatments in the future will likely utilize targeted therapies based on the underlying genetic mutations associated with each individual diagnosis of NMIBC...
  59. doi request reprint Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less
    Max Kates
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    J Urol 186:1247-53. 2011
    ..We used a large, population based registry to assess whether a difference in overall and cardiovascular survival may exist between radical nephrectomy and partial nephrectomy for renal cell carcinoma 2 cm or less...
  60. doi request reprint Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma
    Stephen A Poon
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    BJU Int 103:1622-5. 2009
    ..This might carry a worse prognosis for disease-specific survival (DSS), but reports are limited and contradictory...
  61. ncbi request reprint Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger
    Robert E Mitchell
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Urology 67:260-4. 2006
    ..PN outcomes for large renal cortical tumors have been shown to be worse than outcomes for smaller tumors, but the upper limit of tumor diameter amenable to PN remains controversial...
  62. doi request reprint Comparison of distal ureteral management strategies during laparoscopic nephroureterectomy
    Chad R Ritch
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    J Endourol 25:1149-54. 2011
    ..We describe our contemporary experience with LNU and compare several approaches to the DUBC...
  63. doi request reprint Active Surveillance is Superior to Radical Nephrectomy and Equivalent to Partial Nephrectomy for Preserving Renal Function in Patients with Small Renal Masses: Results from the DISSRM Registry
    Matthew R Danzig
    Herbert Irving Cancer Center, Columbia University College of Physicians and Surgeons, Department of Urology, New York, New York Electronic address
    J Urol 194:903-9. 2015
    ..We compared renal function outcomes among patients in the surveillance and intervention arms of the DISSRM registry...
  64. doi request reprint Renal functional outcomes after surgery for renal cortical tumors
    Max Kates
    Squier Urological Clinic, Columbia University Medical Center, New York, New York, USA
    Curr Opin Urol 21:351-5. 2011
    ..To review the established literature on renal functional outcomes and related pathologies after surgery for renal cortical tumors...
  65. doi request reprint Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes
    William T Berg
    Department of Urology, Herbert Irving Cancer Center, Columbia University College of Physicians and Surgeons, New York, New York
    Prostate 75:1085-91. 2015
    ..We sought to determine maximum wait times between biopsy diagnosis and surgery for localized prostate cancer, beyond which the rate of adverse pathologic outcomes is increased...
  66. pmc Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
    Jing Shen
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, New York, USA
    Prostate 72:1469-77. 2012
    ..It is becoming increasingly evident that microRNAs (miRNAs) are associated with the development and progression of prostate cancer (PCa)...
  67. doi request reprint Effect of statin use on biochemical outcome following radical prostatectomy
    Chad R Ritch
    Columbia University Medical Center NY Presbyterian Hospital, Department of Urology, 161 Ft Washington Ave, HIP 11, New York, NY 10032, USA
    BJU Int 108:E211-6. 2011
    ..To determine the relationship between statin use and biochemical recurrence (BCR) following radical prostatectomy (RP)...
  68. doi request reprint Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin
    Trushar Patel
    Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA
    Urology 76:1240-4. 2010
    ..To investigate the relationship between diabetes and metformin use with outcomes after radical prostatectomy (RP) for clinically localized cancer...
  69. doi request reprint Barriers to the initiation and maintenance of prostate specific antigen screening in Black American and Afro-Caribbean men
    Joshua R Gonzalez
    Department of Urology, Columbia University, New York, New York, USA
    J Urol 180:2403-8; discussion 2408. 2008
    ..We examined the effect of race/ethnicity on the initiation and maintenance of annual prostate specific antigen screening and the role of physicians in screening continuity in these high risk groups...
  70. ncbi request reprint Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy
    Phillip M Pierorazio
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Urology 70:696-701. 2007
    ..To more clearly elucidate the relationship between prostate volume (PV) and prostate cancer parameters...
  71. ncbi request reprint Robot-assisted radical cystoprostatectomy in complex surgical patients: single institution report
    Daniel J Lee
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    Can J Urol 16:4664-9. 2009
    ..To evaluate the safety and feasibility of robotic-assisted radical cystoprostatectomy (RRCP) in a salvage setting for patients with a history of radiation and chemotherapy treatment, complex pelvic anatomy, and significant comorbidities...
  72. ncbi request reprint Gender discrepancies in the diagnosis of renal cortical tumors
    Phillip M Pierorazio
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    World J Urol 25:81-5. 2007
    ..4 vs. 4.5%), women were more likely to have chromophobe histology (11.2 vs. 5.0%; P = 0.006). Differences in demographics, pathologic parameters and histologic sub-typing are observed between men and women treated for renal masses...
  73. doi request reprint Significant change in predicted risk of biochemical recurrence after radical prostatectomy more common in black than in white men
    Melissa A Laudano
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    Urology 74:660-4. 2009
    ..Many nomograms exist to predict the survival outcomes using the pretreatment clinical parameters and post-treatment pathologic parameters. Race might be an important factor affecting their predictive ability...
  74. doi request reprint Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumor
    Alana M Murphy
    Department of Urology, Columbia University Medical Center, New York, NY 10032, USA
    World J Urol 27:501-6. 2009
    ..In addition, the histologic findings, clinical outcomes and perioperative complications were reviewed...
  75. doi request reprint Has the advent of minimally invasive surgery altered the risk profile of patients undergoing prostatectomy?
    Lamont J Barlow
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    Urology 75:427-30. 2010
    ..MIS in many fields has resulted in an expansion in the pool of patients willing to undergo surgery...
  76. doi request reprint Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms
    Adam C Mues
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    Urology 76:620-3. 2010
    ..Most patients undergoing AS are high-risk surgical candidates with Stage T1a lesions. The natural history of larger (Stage cT1bN0M0 and cT2N0M0) RCNs remains undefined...
  77. doi request reprint Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys
    Daniel J Lee
    Department of Urology, Columbia University Medical Center, 161 Fort Washington St, 11th Fl Herbert Irving Pavilion, New York, NY 10032, USA
    World J Urol 29:343-8. 2011
    ..The main objective of this study was to assess the oncologic and functional outcomes after PN in patients with solitary kidneys...
  78. doi request reprint Diagnostic radiation exposure risk in a contemporary cohort of male patients with germ cell tumor
    Mark V Silva
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Urol 187:482-6. 2012
    ..We determined the total amount of diagnostic radiation that a patient with testicular cancer receives during the course of treatment and the associated risk of secondary malignancy...
  79. ncbi request reprint Maximizing intravesical therapy options: is there an advantage to the administration of perioperative mitomycin C prior to an induction course of BCG?
    Gina M Badalato
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    Can J Urol 18:5890-5. 2011
    ..This study sought to evaluate cancer-specific outcomes among patients who received perioperative mitomycin C (MMC) prior to induction BCG versus those who received induction BCG alone...
  80. ncbi request reprint Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles
    Christopher W Johnson
    Department of Urology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Urol Oncol 22:107-11. 2004
    ..A specimen Gleason score of greater than 7 and major Gleason grades greater than 3 were associated with an increased rate of disease progression in this patient group...
  81. ncbi request reprint Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy
    Jay B Shah
    Department of Urology, Columbia University Medical Center, New York, New York, USA
    J Urol 179:136-40. 2008
    ..Using CaPSURE we determined trends in prostate biopsy patterns during the last decade and assessed whether changes in biopsy number have had an impact on outcomes after radical prostatectomy...
  82. ncbi request reprint The evaluation and staging of clinically localized prostate cancer
    Robert E Mitchell
    Columbia University, New York, NY 10032, USA
    Nat Clin Pract Urol 2:356-7. 2005
  83. ncbi request reprint PSA updated: still relevant in the new millennium?
    Jay B Shah
    Department of Urology, Columbia University Medical Center, 161 Fort Washington Avenue, IP 11, New York, NY 10032, USA
    Eur Urol 47:427-32. 2005
  84. doi request reprint Epidemiology, clinical staging, and presentation of renal cell carcinoma
    G Joel DeCastro
    Department of Urology, Columbia University New York Presbyterian Hospital, Atchley Pavillion, 11th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
    Urol Clin North Am 35:581-92; vi. 2008
    ..Disease-specific mortality is actually rising, especially in African American patients. Effective interventions aimed at reducing obesity, hypertension, and smoking may help in reducing the incidence of RCC in the future...
  85. ncbi request reprint Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome
    James M McKiernan
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 62:732-6. 2003
    ....
  86. ncbi request reprint The role of bisphosphonates in preventing skeletal complications of hormonal therapy
    Scott M Gilbert
    Department of Urology, University of Michigan, Ann Arbor, MI 49109, USA
    Urol Clin North Am 33:191-9, vi. 2006
    ..The effect on clinical fractures has not been assessed adequately, but bisphosphonates offer an important potential treatment modality to reduce the risk of osteoporotic fracture in this population of men...
  87. ncbi request reprint Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy
    James M McKiernan
    Columbia University Medical Center, 161 Fort Washington Ave, 11th Floor, Department of Urology, New York, NY 10032, USA
    J Clin Oncol 24:3075-80. 2006
    ..Docetaxel is a microtubule depolymerization inhibitor with unique physiochemical properties, making it an excellent candidate for investigation as an intravesical agent...
  88. doi request reprint Quality of care for testis cancer
    Philipp Dahm
    Department of Urology, University of Florida, Gainesville, FL 32610, USA
    Urol Oncol 27:448-53. 2009
    ..The necessary integration of multiple therapeutic modalities makes testis cancer outcomes highly susceptible to variations in quality of care, which deserves further investigation in well designed population-based studies...
  89. ncbi request reprint Controversies in prostate cancer screening
    Alana M Murphy
    Department of Urology, Columbia University Medical Center, New York, New York 10032, USA
    J Urol 172:1822-4. 2004
    ....
  90. ncbi request reprint Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial
    Jillian L Capodice
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Soc Integr Oncol 7:43-51. 2009
    ..Further studies are warranted to evaluate these agents in patients who are at risk for CaP...
  91. doi request reprint Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades
    Alana M Murphy
    Department of Urology, Columbia University, Medical Center, New York, New York 10032, USA
    Urology 73:1293-7. 2009
    ..Current imaging and biopsy techniques cannot predict the renal tumor histologic features with complete accuracy, and many patients undergo surgery for benign lesions...
  92. ncbi request reprint Epidemiology of male osteoporosis and prostate cancer
    Scott M Gilbert
    Department of Urology, Columbia University Medical Center, New York Presbyterian Hospital, New York, New York 10032, USA
    Curr Opin Urol 15:23-7. 2005
    ....
  93. ncbi request reprint Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American population
    Scott M Gilbert
    Department of Urology, College of Physicians and Surgeons of Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Urol Rep 3:189-93. 2002
    ..This review analyzes the available data regarding variation of the CAG and GGC repeat sequences among different racial and ethnic populations, and the implications of these variations for prostate cancer risk...
  94. doi request reprint Serum tumor markers in the evaluation of male germ cell tumors
    Lamont J Barlow
    Department of Urology, Columbia University Medical Center, Herbert Irving Pavilion, 11th Floor 161 Fort Washington Avenue, New York, NY 10032, USA
    Nat Rev Urol 7:610-7. 2010
    ..Compared to any other solid organ malignancy, the role of serum tumor markers in GCT is unprecedented; these markers are instrumental in the diagnosis and management of testicular GCT...
  95. ncbi request reprint Management of non-retroperitoneal residual germ cell tumor masses
    Mark H Katz
    Department of Urology, Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA
    Urol Clin North Am 34:235-43; abstract x. 2007
    ..After excision of residual viable GCT, evidence suggests that at least intermediate-risk patients who have received only induction chemotherapy benefit from further systemic treatment...
  96. ncbi request reprint Novel therapeutics in the treatment of bladder cancer
    Jay B Shah
    Department of Urology, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Opin Urol 14:287-93. 2004
    ..Here we review the preclinical and clinical developments over the last year in bladder cancer therapeutics...
  97. ncbi request reprint Shifting gene expression profiles during ex vivo culture of renal tumor cells: implications for cancer immunotherapy
    Federica Moschella
    Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Oncol Res 14:133-45. 2003
    ....
  98. ncbi request reprint The evolving role of partial nephrectomy in the management of renal cell carcinoma
    Scott M Gilbert
    Department of Urology, Columbia Presbyterian Medical Center, 161 Fort Washington Avenue, Atchley Pavilion, 11th Floor, New York, NY 10032, USA
    Curr Oncol Rep 5:239-44. 2003
    ..The purpose of this review is to outline and analyze these more recent concerns regarding partial nephrectomy...
  99. ncbi request reprint Treatment of nonretroperitoneal residual germ cell tumor masses
    Mark H Katz
    Department of Urology, Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA
    Urol Oncol 23:431-9. 2005
    ..Patients with residual nonretroperitoneal viable GCT after salvage chemotherapy receive no benefit from additional systemic chemotherapy...
  100. doi request reprint First Prize (tie): Laparoscopic renal cryoablation: efficacy and complications for larger renal masses
    Daniel S Lehman
    Department of Urology, Columbia University, New York, New York, USA
    J Endourol 22:1123-7. 2008
    ..As such, we evaluated our single institution experience with laparoscopic renal cryoablation for complications and oncologic effectiveness as a function of tumor size...
  101. ncbi request reprint The role of intravenous zoledronic acid in the management of high-risk prostate cancer
    Scott M Gilbert
    Squier Urological Clinic, Department of Urology, Columbia Presbyterian Medical Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Curr Opin Urol 13:133-5. 2003
    ..There are limited effective therapies that would persuade most urologists actively to screen for and treat patients who have developed asymptomatic bone metastases...